Search Results

Pazopanib 50 mg  | 99.84%

TargetMol

Pazopanib, a small molecule inhibitor, inhibits multiple protein tyrosine kinases with potential antineoplastic activity. Pazopanib selectively inhibits VEGFR-1, -2 and -3, c-kit and PDGF-R, which may result in inhibition of angiogenesis in tumors in which these receptors are upregulated.

More Information Supplier Page

Mizolastine 50 mg  | 99.77%

TargetMol

Mizolastine (IC50= 47 nM) is a histamine H1-receptor antagonist.It is used in the treatment of allergic reactions such as hay fever (seasonal allergic rhinitis), hives.

More Information Supplier Page

Naloxone hydrochloride 100 mg  | 99.80%

TargetMol

Naloxone hydrochloride is a specific opiate antagonist that has no agonist activity. It is a competitive antagonist at mu, delta, and kappa opioid receptors.

More Information Supplier Page

Palbociclib monohydrochloride 50 mg  | 99.73%

TargetMol

Palbociclib monohydrochloride (PD 0332991 hydrochloride) is a selective inhibitor of CDK4/6 (IC50s: 11/16 nM). It exhibits no inhibition against a panel of 36 additional protein kinases.

More Information Supplier Page

Dequalinium chloride 100 mg  | 99.58%

TargetMol

Dequalinium Chloride, a topical bacteriostat, is a selective blocker of apamin-sensitive K+ channels. It is used in wound dressings and mouth infections and may also have antifungal action, but may cause skin ulceration.

More Information Supplier Page

Dequalinium chloride 200 mg  | 99.58%

TargetMol

Dequalinium Chloride, a topical bacteriostat, is a selective blocker of apamin-sensitive K+ channels. It is used in wound dressings and mouth infections and may also have antifungal action, but may cause skin ulceration.

More Information Supplier Page

Bifendate 200 mg  | 100.00%

TargetMol

Bifendate (Bifendatatum) is commonly used to treat the transaminase elevation that caused by viral hepatitis and drug-induced liver injury.

More Information Supplier Page